Amicus Therapeutics Inc (FOLD)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current FOLD market cap is 2.04B. The company's latest EPS is USD -0.1869 and P/E is -36.44.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 115.08M | 110.4M | 126.67M | 141.52M | 149.71M |
| Operating Income | -3.69M | -27.72M | 14.97M | 21.66M | 15.97M |
| Net Income | -33.84M | -48.42M | -15.7M | -6.73M | 14.74M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 260.89M | 305.51M | 329.23M | 399.36M | 528.3M |
| Operating Income | -247M | -206.43M | -204.43M | -73.49M | 24.88M |
| Net Income | -276.85M | -250.46M | -236.57M | -151.58M | -56.11M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 777.88M | 721.79M | 749.48M | 786.56M | 785.03M |
| Total Liabilities | 617.71M | 591.1M | 616.96M | 607.73M | 590.99M |
| Total Equity | 160.17M | 130.69M | 132.52M | 178.83M | 194.05M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 886.52M | 905.14M | 724.17M | 777.88M | 785.03M |
| Total Liabilities | 600.14M | 597.77M | 601.12M | 617.71M | 590.99M |
| Total Equity | 286.38M | 307.37M | 123.05M | 160.17M | 194.05M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -69.09M | -29.7M | -7M | -29.98M | -33.89M |
| Investing | 98.06M | 7.54M | -14.44M | 19.83M | -560k |
| Financing | 61.68M | -13.31M | -14.17M | 4.02M | 5.12M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -233.29M | -202.49M | -166.58M | -69.09M | -33.89M |
| Investing | -13.58M | 78.76M | 92.32M | 98.06M | -560k |
| Financing | 262.86M | 212.07M | -7.46M | 61.68M | 5.12M |
| Market Cap | 2.04B |
| Price to Earnings Ratio | -36.44 |
| Price to Sales Ratio | 3.87 |
| Price to Cash Ratio | 9.56 |
| Price to Book Ratio | 10.53 |
| Dividend Yield | - |
| Shares Outstanding | 300.12M |
| Average Volume (1 week) | 3.6M |
| Average Volume (1 Month) | 3.83M |
| 52 Week Change | -36.01% |
| 52 Week High | 12.56 |
| 52 Week Low | 6.20 |
| Spread (Intraday) | 0.29 (4.11%) |
| Company Name | Amicus Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.amicusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
